SCIENTURE HOLDINGS, INC. Deferred Tax Assets, Operating Loss Carryforwards
SCIENTURE HOLDINGS, INC. (SCNX) had Deferred Tax Assets, Operating Loss Carryforwards of $1.99 million as of 2024-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-30
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $1.99M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $5.80M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $4.03M.
- 2021-12-31: Deferred Tax Assets, Operating Loss Carryforwards $2.35M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2024-12-31 | $1.99M 10-K · filed 2026-03-30 |
| 2023-12-31 | $5.80M 10-K · filed 2025-03-26 |
| 2022-12-31 | $4.03M 10-K · filed 2024-04-22 |
| 2021-12-31 | $2.35M 10-K · filed 2023-03-27 |
| 2020-12-31 | $1.31M 10-K · filed 2022-03-28 |
| 2019-12-31 | $1.14M 10-K · filed 2021-03-29 |
| 2018-12-31 | $922.85K 10-K · filed 2020-03-30 |
| 2017-12-31 | $963.83K 10-K · filed 2019-03-22 |
| 2016-12-31 | $1.84M 10-K · filed 2018-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |